top of page

🎄 Merry Christmas and Happy New Year! 🎉

已更新:2025年12月23日

As we celebrate this joyful season, it's the perfect time to reflect on the achievements and milestones of the past year.

🌟 2024 Highlights:

  • In the first half of the year, we had the privilege of traveling to UC Berkeley to attend the SPH program, which provided valuable insights and connections.

  • In June, we proudly launched our product during the US BIO 2024, forging strong relationships with new and long-term partners from Japan, the US, Germany, and Argentina.

  • By July, our product successfully entered the drugstore market, marking a significant milestone in making it more accessible to those in need.

  • Throughout the second half of the year, we demonstrated our product at numerous hospitals and engaged with angel investors and VCs for fundraising efforts.

  • This December, we received fantastic news: the final case of our clinical trial has been completed, and we’re preparing to kick off a new trial in the coming year!

✨ Looking ahead, we’re excited to announce the upcoming launch of a new product designed to address oral mucositis. Our commitment to innovation and improving patients’ lives remains steadfast as we continuously refine and expand our solutions.

🙏 We extend our heartfelt thanks to our partners, investors, and supporters for joining us on this journey. Together, we’re making a difference and shaping a brighter future.

🎅 Wishing you all a wonderful holiday season filled with joy, warmth, and cherished moments. Here's to an even more successful and impactful 2024!




 
 
 

最新文章

查看全部
🚀 Exciting News!

💪 We're honored to share that MoleculeX has been ranked 13 Biotech Company in Taiwan on F6S this January 2026. Compared to last year, we've reached several important milestones. More hospitals in Tai

 
 
 

留言


© 2021-2025 MoleculeX Co., Ltd. All right reserved.

bottom of page